Aprea Therapeutics, Inc. ($APRE)
Filing Information
| Accession Number | 0001104659-26-028653 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
50,475
Total Value
$0.00
P&L
+inf% (+$38,472.04)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SrVP/CFO/Prin Fin & Acct Ofcr | Common Stock | โ | Mar 12, 2026 | Grant/Award | 10,095 | $0.00 | $0.00 | 43,528 | Direct | โ | View Details | |
SrVP/CFO/Prin Fin & Acct Ofcr | Stock Options (Right to Buy) | Derivative | Mar 12, 2026 | Grant/Award | 40,380 | $0.00 | $0.00 | 40,380 | Direct | โ | View Details |